Security Snapshot

Synergy CHC Corp. - Common Stock, par value $0.00001 per share (SNYR) Institutional Ownership

CUSIP: 87165D208

13F Institutional Holders and Ownership History from Q4 2024 to Q2 2026

Latest Period

Q1 2026

Institutions Reporting

12

Shares (Excl. Options)

1,675,838

Price

$1.29

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+360,933
Value change
+$436,558
Number of holders
12
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
9,605,095
SEC-reported price per share
$0.21
Insider filing price
$0.21
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • SNYR - Synergy CHC Corp. - Common Stock, par value $0.00001 per share is tracked under CUSIP 87165D208.
  • 12 institutions reported positions in Q1 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 12 to 3 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $2,158,605 to $34,854.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 12 institutions filings for Q1 2026.

Open SEC evidence

Security key

87165D208

Latest holder period

Q1 2026

13F holders

12

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
SNYR
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Knight Therapeutics Inc 20% +17% $3,536,116 +$792,854 1,911,414 +29% KNIGHT THERAPEUTICS INC. 11 Jun 2025

As of 31 Mar 2026, 12 institutional investors reported holding 1,675,838 shares of Synergy CHC Corp. - Common Stock, par value $0.00001 per share (SNYR). This represents 17% of the company’s total 9,605,095 outstanding shares.

13F concentration

Top 16 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
17%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
HEARTLAND ADVISORS INC 5.7% 550,000 0% 0.04% $709,500
GRATIA CAPITAL, LLC 5.7% 550,000 -0.9% 0.67% $709,500
SANDERS MORRIS HARRIS LLC 4.3% 415,452 0.09% $535,933
VANGUARD CAPITAL MANAGEMENT LLC 0.93% 89,770 0% 0% $115,803
VANGUARD FIDUCIARY TRUST CO 0.24% 23,149 0% 0% $29,862
GEODE CAPITAL MANAGEMENT, LLC 0.22% 21,398 -41% 0% $27,603
Williams & Novak, LLC 0.12% 11,945 0.01% $12,184
Warberg Asset Management LLC 0.11% 10,222 -25% 0% $13,186
Tower Research Capital LLC (TRC) 0.03% 2,892 +301% 0% $3,731
UBS Group AG 0.01% 900 -25% 0% $1,161
Clearstead Advisors, LLC 0% 109 +122% 0% $141
CITIGROUP INC 0% 1 0% $1
JANE STREET GROUP, LLC 0% 0 -100% $0
DRW Securities, LLC 0% 0 -100% $0
CITADEL ADVISORS LLC 0% 0 -100% $0
BANK OF AMERICA CORP /DE/ 0% 0 -100% $0

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
7
Latest
Q1 2026
Rows shown
1-7 of 7
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 175,587 $34,854 -$503,450 $0.20 3
2026 Q1 1,675,838 $2,158,605 +$436,558 $1.29 12
2025 Q4 1,297,093 $2,412,592 -$874,135 $1.86 12
2025 Q3 1,640,098 $4,001,535 +$2,950,002 $2.44 11
2025 Q2 427,288 $1,217,771 -$1,153,510 $2.85 6
2025 Q1 905,310 $2,128,805 -$37,888 $2.35 8
2024 Q4 911,017 $4,046,331 +$4,046,331 $4.40 9
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .